Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tricida
Biotech
Adamis, Harpoon, Neoleukin and Tricida grow biotech layoff wave
The four biotechs outlined plans to lay off staff in response to financial headaches and stuttering drug development pipelines.
Nick Paul Taylor
Nov 15, 2022 6:45am
Rubius lays off 82% of staff while Tricida seeks a sale
Nov 3, 2022 9:30am
Phase 3 fail seals fate of Tricida's FDA-rejected kidney drug
Oct 24, 2022 9:50am
Tricida sinks as FDA rejection raises prospect of new trial
Aug 25, 2020 8:20am
Tricida files for $150M IPO to fund kidney disease drug approval
Jun 5, 2018 9:20am
Tricida raises $55M, to get kidney disease data this year
Jul 25, 2016 8:44am
